← Back to Search

Procedure

AC 12L ECG System for Arrhythmia

N/A
Recruiting
Led By Stavros Stavrakis, MD, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 seconds
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an ECG device to see if it accurately records 12-lead ECGs. It will compare the data to a standard ECG system, analyzing for accuracy.

Who is the study for?
This trial is for men and women aged 18 or older who can lie on their back for about 15 minutes to have a special ECG test. It's not suitable for those with recent chest or abdominal surgery, open chest wounds, or missing limbs affecting lead placement.
What is being tested?
The study tests the accuracy and safety of the AC 12L ECG System by AliveCor against a standard GE CardioSoft system. Participants will have both devices record their heart's electrical activity simultaneously to compare results.
What are the potential side effects?
Since this trial involves non-invasive ECG testing, side effects are minimal but may include discomfort from lying still and potential skin irritation from electrode placement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 seconds
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 seconds for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Agreement on AT interval between Kardia 12L and ECG
Agreement on PR interval between Kardia 12L and ECG
Agreement on QRS width between Kardia 12L and ECG

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
474 Previous Clinical Trials
93,491 Total Patients Enrolled
Stavros Stavrakis, MD, PhDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
629 Total Patients Enrolled

Media Library

AC 12L ECG System (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05617001 — N/A
irregular heartbeats Research Study Groups:
irregular heartbeats Clinical Trial 2023: AC 12L ECG System Highlights & Side Effects. Trial Name: NCT05617001 — N/A
AC 12L ECG System (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05617001 — N/A
~63 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top